“I am so proud of the team’s ability to rise to the challenge and excel on every aspect of the project. The cross-functional teamwork was amazing, and when we put the incredible talent we have together with unprecedented focus, determination and collaboration, it speaks to why the team was able to reach this outstanding achievement so quickly.” Maurice Exner – VP of R&D, Assay Development and Clinical Affairs, Diagnostic Solutions Division

“I began working on the COVID-19 test as soon as the first coronavirus genome was published... The enthusiasm we felt as a group was contagious; everyone volunteered extra time and energy to get this test out as soon as possible. Knowing that our work would have a direct impact in the fight against the coronavirus motivated us to put forth our best efforts.” -Joshua Moberly, Scientist 2, Diagnostic Assay Development

“My favorite aspect of this project is how everyone from all functional areas came together to execute as quickly as possible, bringing a critically needed product to market with unprecedented speed. A united front is a POWERFUL thing!” Abby Gajewski-Schwoch – Director of Panther Fusion Assay Marketing, Diagnostic Solutions Division

“I am most proud that our team was able to work with the Centers for Medicare and Medicaid Services, Palmetto MolDx and our industry customers, Quest and Lab Corp, to establish a CPT code and appropriate reimbursement rate in an unprecedented amount of time. This will enable our patients to gain immediate access to COVID-19 testing covered by their insurance companies.” Danielle Scelfo – Senior Director of Health Policy and Reimbursement